← Eichor
Study identifier: NCT06636123 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

Condition: Castration-resistant Prostate Cancer  ·  Sponsor: Virginia Commonwealth University

PhasePhase 1
Planned participants30
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this clinical trial is to determine if GZ17-6.02 delays progression of castration-resistant prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Massey IIT Research Operations  ·  804-628-6430  ·  masseyepd@vcu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Virginia Commonwealth UniversityRichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06636123